Growth Metrics

Eledon Pharmaceuticals (ELDN) Operating Leases (2019 - 2026)

Eledon Pharmaceuticals posted quarterly Operating Leases of $186000.0 for Q1 2026, down 66.49% year-on-year from $555000.0 in Q1 2025, and down 34.28% on a QoQ basis from $283000.0 in Q4 2025.

Eledon Pharmaceuticals (ELDN) has 8 years of Operating Leases data on file, last reported at $186000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 66.49% year-over-year to $186000.0; the trailing twelve-month figure through Mar 2026 stood at $186000.0 (down 66.49% YoY), and the FY2025 full-year result was $283000.0, down 55.78% from the prior year.
  • Operating Leases for Q1 2026 stood at $186000.0, down from $283000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $640000.0 in Q4 2024 and bottomed at $83000.0 in Q3 2023.
  • The 5-year median for Operating Leases is $350000.0 (2022), against an average of $350133.3.
  • The widest annual swing landed in 2022, when Operating Leases surged 924.44%; it then plunged 82.0% in 2023.
  • A 5-year view of Operating Leases shows it stood at $383000.0 in 2022, then sank by 78.33% to $83000.0 in 2023, then jumped by 671.08% to $640000.0 in 2024, then tumbled by 55.78% to $283000.0 in 2025, then tumbled by 34.28% to $186000.0 in 2026.
  • The last three Operating Leases figures came in at $186000.0 (Q1 2026), $283000.0 (Q4 2025), and $376000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 186,000.00
Dec 31, 2025 283,000.00
Sep 30, 2025 376,000.00
Jun 30, 2025 467,000.00
Mar 31, 2025 555,000.00
Dec 31, 2024 640,000.00
Sep 30, 2024 315,000.00
Jun 30, 2024 386,000.00
Sep 30, 2023 83,000.00
Jun 30, 2023 184,000.00
Mar 31, 2023 284,000.00
Dec 31, 2022 383,000.00
Sep 30, 2022 461,000.00
Jun 30, 2022 299,000.00
Mar 31, 2022 350,000.00
Dec 31, 2021 400,000.00
Sep 30, 2021 45,000.00
Jun 30, 2021 90,000.00
Jun 30, 2020 48,000.00
Mar 31, 2020 97,000.00
Dec 31, 2019 144,000.00
Sep 30, 2019 191,000.00
Jun 30, 2019 236,000.00
Mar 31, 2019 281,000.00